René Böttcher
Associate Director for Discovery and Translational Science Consulting
René acts as Associate Director for Discovery and Translational Science Consulting at Clarivate. His team leverages network biology and machine learning to advance pharma and biotech customers’ research projects across a broad spectrum of areas, including target and biomarker identification, patient stratification and drug repositioning.
René has more than 10 years of experience as a computational biologist in both industry and academia. Through working in various fields including cancer biology, cellular signaling, molecular virology and network biology, René gathered a deep understanding of data processing (ETL), analyses, visualization and interpretation using a variety of molecular assay platforms.
René holds a PhD in Bioinformatics from Erasmus University Rotterdam (The Netherlands) and completed this Bachelors and Masters in Biosystems technology / Bioinformatics at the Technical University of Applied Sciences Wildau (Germany).
Latest news
Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development
Expanded capabilities across Cortellis portfolio help life sciences organizations turn trusted intelligence into action and accelerate decision making across the research and development lifecycle London, U.K. — August 6, 2026— Clarivate…
Clarivate Companies to Watch Report Spotlights Seven Innovators Shaping the Next Generation of Obesity Therapies
New report examines novel mechanisms and emerging approaches advancing obesity treatment beyond today’s GLP-1 therapies London, U.K., August 5, 2026 — Clarivate Plc (NYSE:CLVT), a leading global provider of transformative…
Clarivate Appoints Michael Easton as Chief Financial Officer
Experienced Clarivate leader brings more than 25 years of financial and operational expertise LONDON, July 29, 2026: Clarivate Plc (NYSE: CLVT) (“Clarivate” or the “Company”), a leading global provider of transformative intelligence, today…
